The pendulum swings back; estrogen is now beneficial if started at the right time

Climacteric

Volumn 9, Issue 2, 2006, Pages 73-74

  Sturdee, David W ^a   MacLennan, Alastair H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ANGINA PECTORIS; ATHEROMA; COGNITIVE DEFECT; CORONARY ARTERY; EDITORIAL; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HEART PROTECTION; HORMONE RESPONSE; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; MORTALITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 33646484937     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600655431     Document Type: Editorial

References (10)

1. Naftolin F, Schneider HPG, Sturdee DW, for the Executive Committee of the International Menopause Society. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004;7:333-7
2. Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril 2005;83:558-66
3. MacLennan AH, Henderson VW, Paine BJ, et al. Hormone therapy, timing of initiation and cognition in women older than 60 years: the REMEMBER pilot study. Menopause 2006;13:28-36
4. Alexandersen P, Tankó LB, Bagger YZ, et al. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric 2006;9:108-18
5. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Women's Health 2006;15:35-44
6. Hsia J, Langer RD, Manson JE, et al. for the Women' Health Initiative Investigators. Conjugated equine estrogens and coronary disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-65
7. Pines A, Sturdee DW, Birkhäuser M, for the International Menopause Society. Press Statement, February 13, 2006. More data on hormone therapy and coronary heart disease: comments on recent publications from the WHI and Nurses' Health Study. Climacteric 2006;9:75-6
8. Naftolin F, Taylor HS, Karas R. Early initiation of hormone therapy and clinical cardioprotection: the Women's Health Initiative (WHI) could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004;81:1498-501
9. Salpeter SR. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence? Climacteric 2005;8:307-10
10. Salpeter SR, Walsh JM, Greyber E, et al. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004;19:791-804